Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have stated that they assume no responsibility for the contents of PegBio Co., Ltd.’s (2565) announcement.

According to official information, PegBio Co., Ltd. submitted an application to the China Securities Regulatory Commission (CSRC) on November 28, 2025, under the “Guidelines on Application for ‘Full Circulation’ of Domestic Unlisted Shares of H-share Companies” (CSRC Announcement [2023] No. 50). This filing concerns the proposed conversion of 101,702,051 unlisted shares (approximately 26.35% of the total issued shares) on a one-for-one basis into H shares. Following approval from the CSRC and the Stock Exchange of Hong Kong, the newly converted shares will be listed on the Main Board of the Stock Exchange.

The company has indicated that no further shareholders’ meeting is required for this proposed conversion and listing. It has not yet received CSRC approval, and details of the implementation plan are pending finalization. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.